DPC4/SMAD4 expression is lost in a subset of ductal adenocarcinomas of the pancreas but not in endocrine pancreatic tumors and chronic pancreatitis

被引:0
|
作者
Perren, A
Hürlimann, S
Saremaslani, P
Schmid, S
Roth, J
Heitz, PU
Komminoth, P
机构
[1] Univ Zurich, Inst Pathol, Zurich, Switzerland
[2] Inst Pathol, Baden, Switzerland
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
492
引用
收藏
页码:119A / 119A
页数:1
相关论文
共 50 条
  • [41] The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study
    Shin, Sang Hyun
    Kim, Hwa Jung
    Hwang, Dae Wook
    Lee, Jae Hoon
    Song, Ki Byung
    Jun, Eunsung
    Shim, In Kyong
    Hong, Seung-Mo
    Kim, Hyoung Jung
    Park, Kwang-Min
    Lee, Young-Joo
    Kim, Song Cheol
    ONCOTARGET, 2017, 8 (11) : 17945 - 17959
  • [42] DPC4/SMAD4 gene alterations in human cancer, and their functional implications
    Schutte, M
    ANNALS OF ONCOLOGY, 1999, 10 : 56 - 59
  • [43] Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas
    Ando, T
    Sugai, T
    Habano, W
    Jiao, YF
    Suzuki, K
    JOURNAL OF GASTROENTEROLOGY, 2005, 40 (07) : 708 - 715
  • [44] Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas
    Donal MacGrogan
    Mark Pegram
    Dennis Slamon
    Robert Bookstein
    Oncogene, 1997, 15 : 1111 - 1114
  • [45] Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas
    MacGrogan, D
    Pegram, M
    Slamon, D
    Bookstein, R
    ONCOGENE, 1997, 15 (09) : 1111 - 1114
  • [46] DPC4/Smad4 mediated tumor suppression in pancreatic cancer cells through suppression of angiogenesis.
    Schwarte-Waldhoff, I
    Volpert, OV
    Bouck, NP
    Sipos, B
    Hahn, SA
    Klein-Scory, S
    Luettges, J
    Kloeppel, G
    Graeven, U
    Eilert-Micus, C
    Hintelmann, A
    Schmiegel, W
    GASTROENTEROLOGY, 2000, 118 (04) : A50 - A50
  • [47] Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection
    Roland, Christina L.
    Starker, Lee F.
    Rang, Y.
    Chatterjee, Deyali
    Estrella, Jeannelyn
    Rashid, Asif
    Katz, Matthew H.
    Aloia, Thomas A.
    Lee, Jeffrey E.
    Dasari, Arvind
    Yao, James C.
    Fleming, Jason B.
    SURGERY, 2017, 161 (03) : 753 - 759
  • [48] Large-scale analysis for treatment strategy according to genetic alterations of KRAS and DPC4 (SMAD4) genes in pancreatic ductal adenocarcinoma.
    Shin, Sang Hyun
    Kim, Song Cheol
    Song, Ki Byung
    Lee, Jae Hoon
    Hwang, Dae Wook
    Lee, Dong Joo
    Lee, Jung Woo
    Kim, Hyoung Eun
    Jun, Eunsung
    Park, Kwang-Min
    Lee, Young-Joo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [49] DPC4/SMAD4抑癌基因与胆管癌
    唐朝晖
    邹声泉
    临床外科杂志, 2002, (04) : 245 - 247
  • [50] DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression
    Irmgard Schwarte-Waldhoff
    Susanne Klein
    Sabine Blass-Kampmann
    Annette Hintelmann
    Christina Eilert
    Stephan Dreschers
    Holger Kalthoff
    Stephan A Hahn
    Wolff Schmiegel
    Oncogene, 1999, 18 : 3152 - 3158